Simulations Plus SLP announced the launch of GastroPlus X (GPX), which is its latest platform for physiologically based pharmacokinetics and biopharmaceutics (PBPK/PBBM) modeling and simulation. The ...

Simulations Plus SLP recently announced the acquisition of Pro-ficiency Holdings, Inc. and its subsidiaries from QHP Capital and its minority shareholders. The company specializes in offering ...

Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.16. Operator: Greetings, and welcome to the Simulations Plus Third Quarter Fiscal 2024 Financial Results ...

The fiscal 2025 preliminary results and fiscal 2026 guidance set forth above are preliminary and unaudited based on currently available information and management estimates and are subject to ...

Simulations Plus (NASDAQ:SLP) will release its quarterly earnings report on Monday, 2025-12-01. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Simulations Plus to ...

Simulations Plus SLP is gearing up to announce its quarterly earnings on Monday, 2025-07-14. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

Greetings, and welcome to the Simulations Plus Third Quarter Fiscal 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will ...

Simulations Plus, Inc. (NASDAQ: SLP) Q3 2023 Earnings Call Transcript July 6, 2023 Simulations Plus, Inc. reports earnings inline with expectations. Reported EPS is $0.2 EPS, expectations were $0.2.